Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pagoclone in Persistent Developmental Stuttering
NCT00239915Phase 2Completed
- Sponsor
- Pharmacology Research Institute
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pagoclone in stuttering, sponsored by Pharmacology Research Institute. Primary endpoints: Percent Syllables Stuttered at 8 weeks and Stuttering Severity Instrument Version 3 at 8 weeks. Started Apr 2005; status: completed.
02
Drugs
pagoclone
03
Conditions
stuttering
Beyond the preview
Go deeper on NCT00239915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239915.